India approves emergency use of Johnson & Johnson’s single-dose vaccine
India has given US pharmaceutical giant Johnson & Johnson's single-dose Covid-19 vaccine emergency use permission in the country.
"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India," Health Minister Mansukh Mandaviya tweeted today.
"This will further boost our nation's collective fight against Covid-19," he said.
Johnson & Johnson's single-dose jab is the fifth vaccine in India's nationwide vaccination drive that began on January 16 against the virus, reports our New Delhi correspondent.
The vaccines approved by India earlier are Serum Institute of India's Covishield, Bharat Biotech's Covaxin, Moderna of the US and Russia's Sputnik V.
Johnson & Johnson vaccine will be brought to India through a supply agreement with vaccine-maker Biological E Limited.
The health minister's announcement about Johnson & Johnson vaccine being approved came a day after India crossed the milestone of administering 500 million (50 crore) Covid-19 vaccine doses across the country.
Comments